van Trier, Tinka J.
Snaterse, Marjolein
Herings, Ron M. C.
Overbeek, Jetty A.
Peters, Ron J. G.
Jørstad, Harald T.
Funding for this research was provided by:
Genzyme Europe BV (Fellowship)
Article History
Accepted: 20 September 2023
First Online: 23 October 2023
Conflict of interest
: T.J. van Trier, M. Snaterse and R.J.G. Peters declare that they have no competing interests. R.M.C. Herings and J.A. Overbeek are employees of the PHARMO Institute for Drug Outcomes Research. This independent research institute performs financially supported studies for government and related healthcare authorities and pharmaceutical companies. H.T. Jørstad received unrestricted research grants to institution from Bayer, Amgen, and Sanofi and is a member of the national advisory board Amgen (The Netherlands). These funders had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.